Kazakhstan vs Turkmenistan: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Kazakhstan
98.0%
in 2024
Turkmenistan
98.0%
in 2024
Kazakhstan rank
21st
Turkmenistan rank
21st
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Kazakhstan
- Turkmenistan
How they compare
Kazakhstan currently reports 98.0% against 98.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 5 times across 15 shared years of data; in 2010 it was Kazakhstan ahead.
Kazakhstan ranks 21st and Turkmenistan ranks 21st of 192 countries.
Across the 2 decades both report, Kazakhstan averaged higher in 1 and Turkmenistan in 1.
Head to head by decade
| Decade | Kazakhstan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 95.6% | 91.4% | 4.2% | Kazakhstan |
| 2020s | 95.8% | 98.0% | 2.2% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Kazakhstan or Turkmenistan?
- Kazakhstan, at 98.0% against 98.0% in Turkmenistan as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Kazakhstan and Turkmenistan?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Turkmenistan?
- 15 years are reported by both, from 2010 to 2024.
- How do Kazakhstan and Turkmenistan rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Kazakhstan ranks 21st and Turkmenistan ranks 21st of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.